IVD Regulatory Strategy
Optimize pathway selection across 510(k), De Novo, PMA, and EUA with IVD-specific predicate analysis, clinical study requirements, and companion diagnostic strategy.
Purpose-built intelligence for in vitro diagnostic device teams across the product lifecycle.
Optimize pathway selection across 510(k), De Novo, PMA, and EUA with IVD-specific predicate analysis, clinical study requirements, and companion diagnostic strategy.
Design analytical validation strategies with precision, accuracy, and interference study planning informed by FDA guidance, CLSI standards, and competitive submission analysis.
Navigate the EU IVDR transition with automated classification under new risk rules, performance evaluation planning, and common specifications tracking across device classes.
See how Behavior Labs accelerates your strategy.